Global Immortalized Cell Line Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 55503
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Immortalized Cell Line market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Immortalized Cell Line size is estimated to be USD 3086.8 million in 2026 from USD 2532.5 million in 2020, with a change XX% between 2020 and 2021. The global Immortalized Cell Line market size is expected to grow at a CAGR of 5.1% for the next five years.

Market segmentation

Immortalized Cell Line market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Stem Cell Therapy

Cell Transplantation

Drug Transport

Others

Market segment by Application, can be divided into

Pharmaceutical and Biopharmaceutical Companies

Contract Research Organizations

Research Laboratories

Market segment by players, this report covers

Lonza

Thermo Fisher Scientific

JSR

Valneva

Sartorius

Merck

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Immortalized Cell Line

1.2 Classification of Immortalized Cell Line by Type

1.2.1 Overview: Global Immortalized Cell Line Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Immortalized Cell Line Revenue Market Share by Type in 2020

1.2.3 Stem Cell Therapy

1.2.4 Cell Transplantation

1.2.5 Drug Transport

1.2.6 Others

1.3 Global Immortalized Cell Line Market by Application

1.3.1 Overview: Global Immortalized Cell Line Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Pharmaceutical and Biopharmaceutical Companies

1.3.3 Contract Research Organizations

1.3.4 Research Laboratories

1.4 Global Immortalized Cell Line Market Size & Forecast

1.5 Global Immortalized Cell Line Market Size and Forecast by Region

1.5.1 Global Immortalized Cell Line Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Immortalized Cell Line Market Size by Region, (2016-2021)

1.5.3 North America Immortalized Cell Line Market Size and Prospect (2016-2026)

1.5.4 Europe Immortalized Cell Line Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Immortalized Cell Line Market Size and Prospect (2016-2026)

1.5.6 South America Immortalized Cell Line Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Immortalized Cell Line Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Immortalized Cell Line Market Drivers

1.6.2 Immortalized Cell Line Market Restraints

1.6.3 Immortalized Cell Line Trends Analysis

2 Company Profiles

2.1 Lonza

2.1.1 Lonza Details

2.1.2 Lonza Major Business

2.1.3 Lonza Immortalized Cell Line Product and Solutions

2.1.4 Lonza Immortalized Cell Line Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Lonza Recent Developments and Future Plans

2.2 Thermo Fisher Scientific

2.2.1 Thermo Fisher Scientific Details

2.2.2 Thermo Fisher Scientific Major Business

2.2.3 Thermo Fisher Scientific Immortalized Cell Line Product and Solutions

2.2.4 Thermo Fisher Scientific Immortalized Cell Line Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans

2.3 JSR

2.3.1 JSR Details

2.3.2 JSR Major Business

2.3.3 JSR Immortalized Cell Line Product and Solutions

2.3.4 JSR Immortalized Cell Line Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 JSR Recent Developments and Future Plans

2.4 Valneva

2.4.1 Valneva Details

2.4.2 Valneva Major Business

2.4.3 Valneva Immortalized Cell Line Product and Solutions

2.4.4 Valneva Immortalized Cell Line Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Valneva Recent Developments and Future Plans

2.5 Sartorius

2.5.1 Sartorius Details

2.5.2 Sartorius Major Business

2.5.3 Sartorius Immortalized Cell Line Product and Solutions

2.5.4 Sartorius Immortalized Cell Line Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Sartorius Recent Developments and Future Plans

2.6 Merck

2.6.1 Merck Details

2.6.2 Merck Major Business

2.6.3 Merck Immortalized Cell Line Product and Solutions

2.6.4 Merck Immortalized Cell Line Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Merck Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Immortalized Cell Line Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Immortalized Cell Line Players Market Share

3.2.2 Top 10 Immortalized Cell Line Players Market Share

3.2.3 Market Competition Trend

3.3 Immortalized Cell Line Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Immortalized Cell Line Revenue and Market Share by Type (2016-2021)

4.2 Global Immortalized Cell Line Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Immortalized Cell Line Revenue Market Share by Application (2016-2021)

5.2 Immortalized Cell Line Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Immortalized Cell Line Revenue by Type (2016-2026)

6.2 North America Immortalized Cell Line Revenue by Application (2016-2026)

6.3 North America Immortalized Cell Line Market Size by Country

6.3.1 North America Immortalized Cell Line Revenue by Country (2016-2026)

6.3.2 United States Immortalized Cell Line Market Size and Forecast (2016-2026)

6.3.3 Canada Immortalized Cell Line Market Size and Forecast (2016-2026)

6.3.4 Mexico Immortalized Cell Line Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Immortalized Cell Line Revenue by Type (2016-2026)

7.2 Europe Immortalized Cell Line Revenue by Application (2016-2026)

7.3 Europe Immortalized Cell Line Market Size by Country

7.3.1 Europe Immortalized Cell Line Revenue by Country (2016-2026)

7.3.2 Germany Immortalized Cell Line Market Size and Forecast (2016-2026)

7.3.3 France Immortalized Cell Line Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Immortalized Cell Line Market Size and Forecast (2016-2026)

7.3.5 Russia Immortalized Cell Line Market Size and Forecast (2016-2026)

7.3.6 Italy Immortalized Cell Line Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Immortalized Cell Line Revenue by Type (2016-2026)

8.2 Asia-Pacific Immortalized Cell Line Revenue by Application (2016-2026)

8.3 Asia-Pacific Immortalized Cell Line Market Size by Region

8.3.1 Asia-Pacific Immortalized Cell Line Revenue by Region (2016-2026)

8.3.2 China Immortalized Cell Line Market Size and Forecast (2016-2026)

8.3.3 Japan Immortalized Cell Line Market Size and Forecast (2016-2026)

8.3.4 South Korea Immortalized Cell Line Market Size and Forecast (2016-2026)

8.3.5 India Immortalized Cell Line Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Immortalized Cell Line Market Size and Forecast (2016-2026)

8.3.7 Australia Immortalized Cell Line Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Immortalized Cell Line Revenue by Type (2016-2026)

9.2 South America Immortalized Cell Line Revenue by Application (2016-2026)

9.3 South America Immortalized Cell Line Market Size by Country

9.3.1 South America Immortalized Cell Line Revenue by Country (2016-2026)

9.3.2 Brazil Immortalized Cell Line Market Size and Forecast (2016-2026)

9.3.3 Argentina Immortalized Cell Line Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Immortalized Cell Line Revenue by Type (2016-2026)

10.2 Middle East & Africa Immortalized Cell Line Revenue by Application (2016-2026)

10.3 Middle East & Africa Immortalized Cell Line Market Size by Country

10.3.1 Middle East & Africa Immortalized Cell Line Revenue by Country (2016-2026)

10.3.2 Turkey Immortalized Cell Line Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Immortalized Cell Line Market Size and Forecast (2016-2026)

10.3.4 UAE Immortalized Cell Line Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Immortalized Cell Line Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Immortalized Cell Line Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Immortalized Cell Line Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Immortalized Cell Line Revenue (USD Million) by Region (2016-2021)

Table 5. Global Immortalized Cell Line Revenue Market Share by Region (2021-2026)

Table 6. Lonza Corporate Information, Head Office, and Major Competitors

Table 7. Lonza Major Business

Table 8. Lonza Immortalized Cell Line Product and Solutions

Table 9. Lonza Immortalized Cell Line Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors

Table 11. Thermo Fisher Scientific Major Business

Table 12. Thermo Fisher Scientific Immortalized Cell Line Product and Solutions

Table 13. Thermo Fisher Scientific Immortalized Cell Line Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. JSR Corporate Information, Head Office, and Major Competitors

Table 15. JSR Major Business

Table 16. JSR Immortalized Cell Line Product and Solutions

Table 17. JSR Immortalized Cell Line Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Valneva Corporate Information, Head Office, and Major Competitors

Table 19. Valneva Major Business

Table 20. Valneva Immortalized Cell Line Product and Solutions

Table 21. Valneva Immortalized Cell Line Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Sartorius Corporate Information, Head Office, and Major Competitors

Table 23. Sartorius Major Business

Table 24. Sartorius Immortalized Cell Line Product and Solutions

Table 25. Sartorius Immortalized Cell Line Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Merck Corporate Information, Head Office, and Major Competitors

Table 27. Merck Major Business

Table 28. Merck Immortalized Cell Line Product and Solutions

Table 29. Merck Immortalized Cell Line Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Global Immortalized Cell Line Revenue (USD Million) by Players (2019-2021)

Table 31. Global Immortalized Cell Line Revenue Share by Players (2019-2021)

Table 32. Breakdown of Immortalized Cell Line by Company Type (Tier 1, Tier 2 and Tier 3)

Table 33. Immortalized Cell Line Players Head Office, Products and Services Provided

Table 34. Immortalized Cell Line Mergers & Acquisitions in the Past Five Years

Table 35. Immortalized Cell Line New Entrants and Expansion Plans

Table 36. Global Immortalized Cell Line Revenue (USD Million) by Type (2016-2021)

Table 37. Global Immortalized Cell Line Revenue Share by Type (2016-2021)

Table 38. Global Immortalized Cell Line Revenue Forecast by Type (2021-2026)

Table 39. Global Immortalized Cell Line Revenue by Application (2016-2021)

Table 40. Global Immortalized Cell Line Revenue Forecast by Application (2021-2026)

Table 41. North America Immortalized Cell Line Revenue by Type (2016-2021) & (USD Million)

Table 42. North America Immortalized Cell Line Revenue by Type (2021-2026) & (USD Million)

Table 43. North America Immortalized Cell Line Revenue by Application (2016-2021) & (USD Million)

Table 44. North America Immortalized Cell Line Revenue by Application (2021-2026) & (USD Million)

Table 45. North America Immortalized Cell Line Revenue by Country (2016-2021) & (USD Million)

Table 46. North America Immortalized Cell Line Revenue by Country (2021-2026) & (USD Million)

Table 47. Europe Immortalized Cell Line Revenue by Type (2016-2021) & (USD Million)

Table 48. Europe Immortalized Cell Line Revenue by Type (2021-2026) & (USD Million)

Table 49. Europe Immortalized Cell Line Revenue by Application (2016-2021) & (USD Million)

Table 50. Europe Immortalized Cell Line Revenue by Application (2021-2026) & (USD Million)

Table 51. Europe Immortalized Cell Line Revenue by Country (2016-2021) & (USD Million)

Table 52. Europe Immortalized Cell Line Revenue by Country (2021-2026) & (USD Million)

Table 53. Asia-Pacific Immortalized Cell Line Revenue by Type (2016-2021) & (USD Million)

Table 54. Asia-Pacific Immortalized Cell Line Revenue by Type (2021-2026) & (USD Million)

Table 55. Asia-Pacific Immortalized Cell Line Revenue by Application (2016-2021) & (USD Million)

Table 56. Asia-Pacific Immortalized Cell Line Revenue by Application (2021-2026) & (USD Million)

Table 57. Asia-Pacific Immortalized Cell Line Revenue by Region (2016-2021) & (USD Million)

Table 58. Asia-Pacific Immortalized Cell Line Revenue by Region (2021-2026) & (USD Million)

Table 59. South America Immortalized Cell Line Revenue by Type (2016-2021) & (USD Million)

Table 60. South America Immortalized Cell Line Revenue by Type (2021-2026) & (USD Million)

Table 61. South America Immortalized Cell Line Revenue by Application (2016-2021) & (USD Million)

Table 62. South America Immortalized Cell Line Revenue by Application (2021-2026) & (USD Million)

Table 63. South America Immortalized Cell Line Revenue by Country (2016-2021) & (USD Million)

Table 64. South America Immortalized Cell Line Revenue by Country (2021-2026) & (USD Million)

Table 65. Middle East & Africa Immortalized Cell Line Revenue by Type (2016-2021) & (USD Million)

Table 66. Middle East & Africa Immortalized Cell Line Revenue by Type (2021-2026) & (USD Million)

Table 67. Middle East & Africa Immortalized Cell Line Revenue by Application (2016-2021) & (USD Million)

Table 68. Middle East & Africa Immortalized Cell Line Revenue by Application (2021-2026) & (USD Million)

Table 69. Middle East & Africa Immortalized Cell Line Revenue by Country (2016-2021) & (USD Million)

Table 70. Middle East & Africa Immortalized Cell Line Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Immortalized Cell Line Picture

Figure 2. Global Immortalized Cell Line Revenue Market Share by Type in 2020

Figure 3. Stem Cell Therapy

Figure 4. Cell Transplantation

Figure 5. Drug Transport

Figure 6. Others

Figure 7. Immortalized Cell Line Revenue Market Share by Application in 2020

Figure 8. Pharmaceutical and Biopharmaceutical Companies Picture

Figure 9. Contract Research Organizations Picture

Figure 10. Research Laboratories Picture

Figure 11. Global Immortalized Cell Line Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 12. Global Immortalized Cell Line Revenue and Forecast (2016-2026) & (USD Million)

Figure 13. Global Immortalized Cell Line Revenue Market Share by Region (2016-2026)

Figure 14. Global Immortalized Cell Line Revenue Market Share by Region in 2020

Figure 15. North America Immortalized Cell Line Revenue (USD Million) and Growth Rate (2016-2026)

Figure 16. Europe Immortalized Cell Line Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Asia-Pacific Immortalized Cell Line Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. South America Immortalized Cell Line Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Middle East and Africa Immortalized Cell Line Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Immortalized Cell Line Market Drivers

Figure 21. Immortalized Cell Line Market Restraints

Figure 22. Immortalized Cell Line Market Trends

Figure 23. Lonza Recent Developments and Future Plans

Figure 24. Thermo Fisher Scientific Recent Developments and Future Plans

Figure 25. JSR Recent Developments and Future Plans

Figure 26. Valneva Recent Developments and Future Plans

Figure 27. Sartorius Recent Developments and Future Plans

Figure 28. Merck Recent Developments and Future Plans

Figure 29. Global Immortalized Cell Line Revenue Share by Players in 2020

Figure 30. Immortalized Cell Line Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 31. Global Top 3 Players Immortalized Cell Line Revenue Market Share in 2020

Figure 32. Global Top 10 Players Immortalized Cell Line Revenue Market Share in 2020

Figure 33. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 34. Global Immortalized Cell Line Revenue Share by Type in 2020

Figure 35. Global Immortalized Cell Line Market Share Forecast by Type (2021-2026)

Figure 36. Global Immortalized Cell Line Revenue Share by Application in 2020

Figure 37. Global Immortalized Cell Line Market Share Forecast by Application (2021-2026)

Figure 38. North America Immortalized Cell Line Sales Market Share by Type (2016-2026)

Figure 39. North America Immortalized Cell Line Sales Market Share by Application (2016-2026)

Figure 40. North America Immortalized Cell Line Revenue Market Share by Country (2016-2026)

Figure 41. United States Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Canada Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Mexico Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Europe Immortalized Cell Line Sales Market Share by Type (2016-2026)

Figure 45. Europe Immortalized Cell Line Sales Market Share by Application (2016-2026)

Figure 46. Europe Immortalized Cell Line Revenue Market Share by Country (2016-2026)

Figure 47. Germany Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Immortalized Cell Line Sales Market Share by Type (2016-2026)

Figure 53. Asia-Pacific Immortalized Cell Line Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Immortalized Cell Line Revenue Market Share by Region (2016-2026)

Figure 55. China Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Japan Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. South Korea Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. India Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Southeast Asia Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Australia Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. South America Immortalized Cell Line Sales Market Share by Type (2016-2026)

Figure 62. South America Immortalized Cell Line Sales Market Share by Application (2016-2026)

Figure 63. South America Immortalized Cell Line Revenue Market Share by Country (2016-2026)

Figure 64. Brazil Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Argentina Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Middle East and Africa Immortalized Cell Line Sales Market Share by Type (2016-2026)

Figure 67. Middle East and Africa Immortalized Cell Line Sales Market Share by Application (2016-2026)

Figure 68. Middle East and Africa Immortalized Cell Line Revenue Market Share by Country (2016-2026)

Figure 69. Turkey Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Saudi Arabia Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. UAE Immortalized Cell Line Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Methodology

Figure 73. Research Process and Data Source